Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Lintzeris

Showing results (141-150 of 196) with videos related to

Pageof 20
Sort By:
Harm Reduction Journal|May 8, 2020
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemicAdrian Dunlop, Buddhima Lokuge, Debbie Masters, et al.
Drug and Alcohol Dependence|August 10, 2020
Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trialNicholas Lintzeris, Llewellyn Mills, Adrian Dunlop, et al.
Emergency Medicine Australasia : EMA|January 12, 2022
Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departmentsEleanor Black, Lauren A Monds, Betty Chan, et al.
Addiction (Abingdon, England)|November 17, 2020
Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populationsRachel M Deacon, Kristie Mammen, Raimondo Bruno, et al.
International Journal of Integrated Care|April 30, 2020
Evaluation of an Assertive Management and Integrated Care Service for Frequent Emergency Department Attenders with Substance Use Disorders: The Impact Project: Evaluating an assertive management service for frequent ED attenders with substance use disordersNicholas Lintzeris, Rachel M Deacon, Marian Shanahan, et al.
Journal of Sleep Research|October 20, 2020
The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trialDanielle McCartney, Ashling D Isik, Kieron Rooney, et al.
Pain Medicine (Malden, Mass.)|March 13, 2019
Antidepressant Use Among People Prescribed Opioids for Chronic Noncancer PainNatasa Gisev, Suzanne Nielsen, Gabrielle Campbell, et al.
Plos One|October 3, 2022
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawalLiam S Acheson, Nadine Ezard, Nicholas Lintzeris, et al.
Pharmacoepidemiology and Drug Safety|January 20, 2017
Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatmentSuzanne Nielsen, Natasa Gisev, Raimondo Bruno, et al.
The International Journal on Drug Policy|March 13, 2024
Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retentionLiam S Acheson, Simon Clay, Rebecca McKetin, et al.
Pageof 20

Showing results (141-150 of 196) with videos related to

Sort By:
Pageof 20
Harm Reduction Journal|May 8, 2020
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemicAdrian Dunlop, Buddhima Lokuge, Debbie Masters, et al.
Drug and Alcohol Dependence|August 10, 2020
Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trialNicholas Lintzeris, Llewellyn Mills, Adrian Dunlop, et al.
Emergency Medicine Australasia : EMA|January 12, 2022
Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departmentsEleanor Black, Lauren A Monds, Betty Chan, et al.
Addiction (Abingdon, England)|November 17, 2020
Assessing the concurrent validity, inter-rater reliability and test-re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populationsRachel M Deacon, Kristie Mammen, Raimondo Bruno, et al.
International Journal of Integrated Care|April 30, 2020
Evaluation of an Assertive Management and Integrated Care Service for Frequent Emergency Department Attenders with Substance Use Disorders: The Impact Project: Evaluating an assertive management service for frequent ED attenders with substance use disordersNicholas Lintzeris, Rachel M Deacon, Marian Shanahan, et al.
Journal of Sleep Research|October 20, 2020
The effect of daily aerobic cycling exercise on sleep quality during inpatient cannabis withdrawal: A randomised controlled trialDanielle McCartney, Ashling D Isik, Kieron Rooney, et al.
Pain Medicine (Malden, Mass.)|March 13, 2019
Antidepressant Use Among People Prescribed Opioids for Chronic Noncancer PainNatasa Gisev, Suzanne Nielsen, Gabrielle Campbell, et al.
Plos One|October 3, 2022
Trial protocol of an open label pilot study of lisdexamfetamine for the treatment of acute methamphetamine withdrawalLiam S Acheson, Nadine Ezard, Nicholas Lintzeris, et al.
Pharmacoepidemiology and Drug Safety|January 20, 2017
Defined daily doses (DDD) do not accurately reflect opioid doses used in contemporary chronic pain treatmentSuzanne Nielsen, Natasa Gisev, Raimondo Bruno, et al.
The International Journal on Drug Policy|March 13, 2024
Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retentionLiam S Acheson, Simon Clay, Rebecca McKetin, et al.
Pageof 20